IGNITE network: Response of patients to genomic medicine interventions
- PMID: 30895746
- PMCID: PMC6503007
- DOI: 10.1002/mgg3.636
IGNITE network: Response of patients to genomic medicine interventions
Abstract
Background: The IGNITE network funds six genomic medicine projects. Though interventions varied, we hypothesized that synergies across projects could be leveraged to better understand the participant experiences with genomic medicine interventions. Therefore, we performed cross-network analyses to identify associations between participant demographics and attitudes toward the intervention (attitude), plan to share results (share), and quality of life (QOL).
Methods: Data collection for demographics, attitude, share, and QOL surveys were standardized across projects. Recruitment and survey administration varied by each project's protocol.
Results: Participants (N = 6,817) were 67.2% (N = 4,584) female, and 37.4% (N = 3,544) were minority. Mean age = 54.0 (sd 14.a). Younger participants were as follows: (1) more positive in attitude pre-intervention (1.15-fold decrease/10-year age increase (OR)) and more negative after (1.14-fold increase OR); (2) higher in QOL pre-intervention (1.07-fold increase OR) and postintervention; (3) more likely to share results (1.12-fold increase OR). Race was significant when sharing results (white participants increased OR = 1.88), but not for change in QOL pre-postintervention or attitude.
Conclusion: Our findings demonstrate the feasibility of this approach and identified a few key themes which are as follows: age was consistently significant across the three outcomes, whereas race had less of an impact than expected. However, these are only associations and thus warrant further study.
Keywords: IGNITE; attitude; common measures; genomic medicine; plan to share; quality of life.
© 2019 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc.
Conflict of interest statement
None of the authors have any conflicts of interest to disclose. This work was funded by the NIH grants cited in the manuscript.
Figures
Similar articles
-
The IGNITE network: a model for genomic medicine implementation and research.BMC Med Genomics. 2016 Jan 5;9:1. doi: 10.1186/s12920-015-0162-5. BMC Med Genomics. 2016. PMID: 26729011 Free PMC article.
-
Adults' perceptions of genetic counseling and genetic testing.Appl Nurs Res. 2015 Feb;28(1):25-30. doi: 10.1016/j.apnr.2014.03.001. Epub 2014 Mar 13. Appl Nurs Res. 2015. PMID: 24794711
-
Utilization of Genetic Counseling after Direct-to-Consumer Genetic Testing: Findings from the Impact of Personal Genomics (PGen) Study.J Genet Couns. 2017 Dec;26(6):1270-1279. doi: 10.1007/s10897-017-0106-7. Epub 2017 May 16. J Genet Couns. 2017. PMID: 28512697 Free PMC article.
-
Outcomes of a Randomized Controlled Trial of Genomic Counseling for Patients Receiving Personalized and Actionable Complex Disease Reports.J Genet Couns. 2017 Oct;26(5):980-998. doi: 10.1007/s10897-017-0073-z. Epub 2017 Mar 27. J Genet Couns. 2017. PMID: 28345121 Free PMC article. Clinical Trial.
-
Measurement of quality of life and attitudes towards illness in children and young people with chronic kidney disease.Qual Life Res. 2017 Sep;26(9):2409-2419. doi: 10.1007/s11136-017-1605-6. Epub 2017 May 27. Qual Life Res. 2017. PMID: 28551835 Review.
Cited by
-
Clinical implementation of drug metabolizing gene-based therapeutic interventions worldwide.Hum Genet. 2022 Jun;141(6):1137-1157. doi: 10.1007/s00439-021-02369-x. Epub 2021 Oct 1. Hum Genet. 2022. PMID: 34599365 Review.
-
Patients' and professionals' views related to ethical issues in precision medicine: a mixed research synthesis.BMC Med Ethics. 2021 Aug 31;22(1):116. doi: 10.1186/s12910-021-00682-8. BMC Med Ethics. 2021. PMID: 34465328 Free PMC article. Review.
-
Real-World Impact of a Pharmacogenomics-Enriched Comprehensive Medication Management Program.J Pers Med. 2022 Mar 8;12(3):421. doi: 10.3390/jpm12030421. J Pers Med. 2022. PMID: 35330421 Free PMC article.
-
Public Interest in Population Genetic Screening for Cancer Risk.Front Genet. 2022 Jul 22;13:886640. doi: 10.3389/fgene.2022.886640. eCollection 2022. Front Genet. 2022. PMID: 35938028 Free PMC article.
References
-
- Bowen, S. , Muin, J. K. (2018). Consumer genetic testing is booming: But what are the benefits and harms to individuals and populations? Atlanta, GA: Office of Public Health Genomics, Centers for Disease Control and Prevention. Genomics and Health Impact Blog.
-
- Busija, L. , Pausenberger, E. , Haines, T. P. , Haymes, S. , Buchbinder, R. , & Osborne, R. H. (2011). Adult measures of general health and health‐related quality of life: Medical Outcomes Study Short Form 36‐Item (SF‐36) and Short Form 12‐Item (SF‐12) Health Surveys, Nottingham Health Profile (NHP), Sickness Impact Profile (SIP), Medical Outcomes Study Short Form 6D (SF‐6D), Health Utilities Index Mark 3 (HUI3), Quality of Well‐Being Scale (QWB), and Assessment of Quality of Life (AQoL). Arthritis Care & Research, 63(Suppl 11), S383–412. 10.1002/acr.20541 - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical